Platform Clinical Study for Conquering Scleroderma

Clinical trial NCT06195072 · RECRUITING

Trial details

NCT number: NCT06195072
Sponsor: Scleroderma Research Foundation, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Interstitial Lung Disease Due to Systemic Disease Scleroderma

Start date: 2024-04-15
Primary completion: 2026-11-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.